Treatments for Severe Cutaneous Adverse Reactions

Severe cutaneous adverse reaction (SCAR) is life-threatening. It consists of Stevens-Johnson syndrome/toxic epidermal necrolysis (SJS/TEN), drug reaction with eosinophilia and systemic symptoms (DRESS), acute generalized exanthematous pustulosis (AGEP), and generalized bullous fixed drug eruptions (...

Full description

Saved in:
Bibliographic Details
Main Authors: Yung-Tsu Cho, Chia-Yu Chu
Format: Article
Language:English
Published: Wiley 2017-01-01
Series:Journal of Immunology Research
Online Access:http://dx.doi.org/10.1155/2017/1503709
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832554269043064832
author Yung-Tsu Cho
Chia-Yu Chu
author_facet Yung-Tsu Cho
Chia-Yu Chu
author_sort Yung-Tsu Cho
collection DOAJ
description Severe cutaneous adverse reaction (SCAR) is life-threatening. It consists of Stevens-Johnson syndrome/toxic epidermal necrolysis (SJS/TEN), drug reaction with eosinophilia and systemic symptoms (DRESS), acute generalized exanthematous pustulosis (AGEP), and generalized bullous fixed drug eruptions (GBFDE). In the past years, emerging studies have provided better understandings regarding the pathogenesis of these diseases. These diseases have unique presentations and distinct pathomechanisms. Therefore, theoretically, the options of treatments might be different among various SCARs. However, due to the rarity of these diseases, sufficient evidence is still lacking to support the best choice of treatment for patients with SCAR. Herein, we will provide a concise review with an emphasis on the characteristics and treatments of each SCAR. It may serve as a guidance based on the current best of knowledge and may shed light on the directions for further investigations.
format Article
id doaj-art-1d96004146aa4f8b85f405568e6db93f
institution Kabale University
issn 2314-8861
2314-7156
language English
publishDate 2017-01-01
publisher Wiley
record_format Article
series Journal of Immunology Research
spelling doaj-art-1d96004146aa4f8b85f405568e6db93f2025-02-03T05:51:49ZengWileyJournal of Immunology Research2314-88612314-71562017-01-01201710.1155/2017/15037091503709Treatments for Severe Cutaneous Adverse ReactionsYung-Tsu Cho0Chia-Yu Chu1Department of Dermatology, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, TaiwanDepartment of Dermatology, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, TaiwanSevere cutaneous adverse reaction (SCAR) is life-threatening. It consists of Stevens-Johnson syndrome/toxic epidermal necrolysis (SJS/TEN), drug reaction with eosinophilia and systemic symptoms (DRESS), acute generalized exanthematous pustulosis (AGEP), and generalized bullous fixed drug eruptions (GBFDE). In the past years, emerging studies have provided better understandings regarding the pathogenesis of these diseases. These diseases have unique presentations and distinct pathomechanisms. Therefore, theoretically, the options of treatments might be different among various SCARs. However, due to the rarity of these diseases, sufficient evidence is still lacking to support the best choice of treatment for patients with SCAR. Herein, we will provide a concise review with an emphasis on the characteristics and treatments of each SCAR. It may serve as a guidance based on the current best of knowledge and may shed light on the directions for further investigations.http://dx.doi.org/10.1155/2017/1503709
spellingShingle Yung-Tsu Cho
Chia-Yu Chu
Treatments for Severe Cutaneous Adverse Reactions
Journal of Immunology Research
title Treatments for Severe Cutaneous Adverse Reactions
title_full Treatments for Severe Cutaneous Adverse Reactions
title_fullStr Treatments for Severe Cutaneous Adverse Reactions
title_full_unstemmed Treatments for Severe Cutaneous Adverse Reactions
title_short Treatments for Severe Cutaneous Adverse Reactions
title_sort treatments for severe cutaneous adverse reactions
url http://dx.doi.org/10.1155/2017/1503709
work_keys_str_mv AT yungtsucho treatmentsforseverecutaneousadversereactions
AT chiayuchu treatmentsforseverecutaneousadversereactions